Policy paper

Amendment to the Health Service Branded Medicines (Control of Prices and Supply of Information) (No. 2) Regulations 2008

This publication was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government

Amendment to the Health Service Branded Medicines (Control of Prices and Supply of Information) (No. 2) Regulations 2008.

Documents

impact assessment number 6089

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

list of products not exempt under section 4 of the regulations

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

excel list of products not exempt under section 4 of the regulations

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail

Companies that do not belong to a voluntary scheme are subject to a statutory arrangement known as the Health Service Branded Medicines (Control of Prices and Supply of Information) (No. 2) Regulations 2008. The Secretary of State for Health has made an amendment to these regulations which came into force on 1 January 2013.